Endonovo Therapeutics, Inc.
Pembelian

$ENDV Alerted at .0150 Currently .0850 4th Major Leg up Starting

255
1. Won their Injunction
2. PreClinical Trials for its Immunotronics Platform
3. Filed for Orphan Drug Status
4. Over 20 patents
5. Form 4s filed by insiders
6. Converts being bought by Company and Institutions
7. Uplistment
8. President and CEO has been filing form 4's everyday so far the past couple weeks

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.